Shanghai Shen Lian Biomedical Corporation
SSE:688098.SS
5.99 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 146.206 | 44.976 | 52.743 | 44.213 | 114.614 | 155.862 | 384.311 | 145.983 | 165.339 | 136.521 | 117.63 | 221.947 |
| Short Term Investments
| 43.815 | 162.375 | 305.123 | 424.077 | 472.454 | 532.173 | 0 | 0 | 0 | 40 | 120 | 3.013 |
| Cash and Short Term Investments
| 190.021 | 207.351 | 357.865 | 468.29 | 587.068 | 155.862 | 384.311 | 145.983 | 165.339 | 136.521 | 117.63 | 221.947 |
| Net Receivables
| 264.568 | 277.061 | 222.758 | 160.61 | 134.94 | 0 | 55.919 | 79.194 | 0 | 25.94 | 0 | 0 |
| Inventory
| 95.103 | 111.789 | 115.329 | 103.421 | 71.172 | 55.651 | 52.856 | 51.629 | 47.479 | 45.229 | 48.612 | 46.515 |
| Other Current Assets
| 1.138 | 2.09 | 9.552 | 1.14 | 0.679 | 533.809 | 3.832 | 6.8 | 6.062 | 41.817 | 120 | 4.945 |
| Total Current Assets
| 550.831 | 598.29 | 705.504 | 733.461 | 793.859 | 849.979 | 496.918 | 283.606 | 261.751 | 252.501 | 324.707 | 348.489 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 810.878 | 823.104 | 776.657 | 768.552 | 642.76 | 546.938 | 465.631 | 366.258 | 303.831 | 171.109 | 151.214 | 131.741 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 135.848 | 135.951 | 95.287 | 68.184 | 35.111 | 33.834 | 34.442 | 35.236 | 36.031 | 36.825 | 37.652 | 5.954 |
| Goodwill and Intangible Assets
| 135.848 | 135.951 | 95.287 | 68.184 | 35.111 | 33.834 | 34.442 | 35.236 | 36.031 | 36.825 | 37.652 | 5.954 |
| Long Term Investments
| -37.232 | 0 | -303.546 | -422.506 | -470.883 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 13.26 | 5.137 | 6.502 | 7.081 | 8.386 | 3.958 | 3.835 | 3.722 | 4.355 | 9.267 | 14.815 | 16.295 |
| Other Non-Current Assets
| 80.533 | 0 | 324.68 | 443.693 | 505.237 | 12.917 | 12.295 | 3.371 | 1.824 | 20.614 | 0.504 | 29.05 |
| Total Non-Current Assets
| 1,003.287 | 995.704 | 899.58 | 865.003 | 720.61 | 597.647 | 516.203 | 408.587 | 346.04 | 237.815 | 204.184 | 183.04 |
| Total Assets
| 1,554.118 | 1,593.994 | 1,605.084 | 1,598.464 | 1,514.469 | 1,447.626 | 1,013.122 | 692.193 | 607.791 | 490.316 | 528.892 | 531.529 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 5.438 | 5.144 | 8.86 | 11.333 | 7.536 | 2.95 | 9.151 | 3.855 | 2.977 | 3.216 | 4.969 | 7.83 |
| Short Term Debt
| 14.008 | 0.334 | 0.136 | 0.132 | 0.138 | 10.022 | 0 | 3.739 | 0 | 45 | 0 | 0 |
| Tax Payables
| 1.599 | 2.346 | 13.113 | 8.689 | 1.695 | 0.933 | 0.744 | 0.391 | 0.53 | 2.656 | 27.736 | 20.346 |
| Deferred Revenue
| 0 | 0 | 10.505 | 85.238 | 14.314 | 101.931 | 9.668 | 78.151 | 11.81 | 107.288 | 0 | 0 |
| Other Current Liabilities
| 95.156 | 68.679 | 64.602 | 85.054 | 82.19 | 132.426 | 131.619 | 110.925 | 138.815 | 122.033 | 254.619 | 175.767 |
| Total Current Liabilities
| 116.201 | 76.503 | 97.217 | 113.529 | 105.873 | 146.331 | 151.182 | 118.91 | 142.322 | 172.905 | 287.324 | 203.944 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 1.006 | 0.917 | 0.31 | 0.382 | 0.514 | 20 | 30 | 24.009 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.081 | 9.488 | 10.364 | 11.299 | 12.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.207 | 0.018 | 0.318 | 0.267 | 0.113 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 10.364 | 0 | 12.217 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 12.294 | 10.423 | 10.992 | 11.947 | 12.331 | 20 | 30 | 24.009 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 128.495 | 86.926 | 108.209 | 125.477 | 118.204 | 166.331 | 181.182 | 142.919 | 142.322 | 172.905 | 287.324 | 203.944 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 410.644 | 410.644 | 410.644 | 410.644 | 409.7 | 409.7 | 359.7 | 99.15 | 99.15 | 86.15 | 86.15 | 86.15 |
| Retained Earnings
| 404.722 | 463.834 | 468.572 | 450.11 | 392.471 | 308.7 | 267.314 | 198.407 | 124.469 | 68.259 | 152.576 | 241.436 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 85.518 | 88.923 | 89.387 | 72.702 | 41.353 | 204.925 | 251.718 | 241.85 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 595.93 | 528.736 | 617.659 | 618.123 | 521.543 | 562.896 | 204.925 | 251.718 | 241.85 | 163.003 | 2.842 | 0 |
| Total Shareholders Equity
| 1,411.295 | 1,488.732 | 1,496.874 | 1,478.877 | 1,396.413 | 1,281.296 | 831.94 | 549.274 | 465.469 | 317.412 | 241.568 | 327.585 |
| Total Equity
| 1,425.622 | 1,507.068 | 1,496.874 | 1,472.988 | 1,396.266 | 1,281.296 | 831.94 | 549.274 | 465.469 | 317.412 | 241.568 | 327.585 |
| Total Liabilities & Shareholders Equity
| 1,554.118 | 1,593.994 | 1,605.084 | 1,598.464 | 1,514.469 | 1,447.626 | 1,013.122 | 692.193 | 607.791 | 490.316 | 528.892 | 531.529 |